These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25767713)
1. Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert®): about one case and review of the therapeutic arsenal. Lipski SM; Casimir G; Vanlommel M; Jeanmaire M; Dolhen P Clin Case Rep; 2015 Feb; 3(2):126-30. PubMed ID: 25767713 [TBL] [Abstract][Full Text] [Related]
2. The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema. Hermanrud T; Duus N; Bygum A; Rasmussen ER Case Rep Emerg Med; 2016; 2016():3930923. PubMed ID: 27123347 [TBL] [Abstract][Full Text] [Related]
3. C1 Esterase Inhibitor for Ace-Inhibitor Angioedema: A Case Series and Literature Review. Perza M; Koczirka S; Nomura JT J Emerg Med; 2020 Mar; 58(3):e121-e127. PubMed ID: 31843319 [TBL] [Abstract][Full Text] [Related]
4. C1 Esterase Inhibitor (Berinert) for ACE Inhibitor-Induced Angioedema: Two Case Reports. Leibfried M; Kovary A J Pharm Pract; 2017 Dec; 30(6):668-671. PubMed ID: 27837046 [TBL] [Abstract][Full Text] [Related]
5. Effect of C1-Esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema. Greve J; Bas M; Hoffmann TK; Schuler PJ; Weller P; Kojda G; Strassen U Laryngoscope; 2015 Jun; 125(6):E198-202. PubMed ID: 25583256 [TBL] [Abstract][Full Text] [Related]
6. Cost-utility analysis of Ruconest(®) (conestat alfa) compared to Berinert(®) P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema. Kawalec P; Holko P; Paszulewicz A Postepy Dermatol Alergol; 2013 Jun; 30(3):152-8. PubMed ID: 24278067 [TBL] [Abstract][Full Text] [Related]
7. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078 [TBL] [Abstract][Full Text] [Related]
10. Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study. Zanichelli A; Azin GM; Cristina F; Vacchini R; Caballero T Orphanet J Rare Dis; 2018 Apr; 13(1):51. PubMed ID: 29631595 [TBL] [Abstract][Full Text] [Related]
11. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor. Sigler C; Annis K; Cooper K; Haber H; Van deCarr S Arch Dermatol; 1997 Aug; 133(8):972-5. PubMed ID: 9267242 [TBL] [Abstract][Full Text] [Related]
12. [Profhylaxis and treatment of hereditary and acquired angioedema at HUB; use of the C1-esterase inhibitor]. Pastó Cardona L; Bordas Orpinell J; Mercadal Orfila G; Pérez de la Vara A; Jódar Massanés R Farm Hosp; 2003; 27(6):346-52. PubMed ID: 14974880 [TBL] [Abstract][Full Text] [Related]
13. Severe migratory Angioedema due to ACE inhibitors use. Peltekis G; Palaskas D; Samanidou M; Fragakis A; Alexopoulos K; Kotsani A; Vogiatzis I; Kyrmizakis E Hippokratia; 2009 Apr; 13(2):122-4. PubMed ID: 19561786 [TBL] [Abstract][Full Text] [Related]
14. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema. Bork K Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050 [TBL] [Abstract][Full Text] [Related]
15. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema. Culley CM; DiBridge JN; Wilson GL Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949 [TBL] [Abstract][Full Text] [Related]